» Articles » PMID: 35873710

Chlorpromazine and Promethazine (C+P) Reduce Brain Injury After Ischemic Stroke Through the PKC-/NOX/MnSOD Pathway

Overview
Publisher Wiley
Specialties Biochemistry
Pathology
Date 2022 Jul 25
PMID 35873710
Authors
Affiliations
Soon will be listed here.
Abstract

Cerebral ischemia-reperfusion (I/R) incites neurologic damage through a myriad of complex pathophysiological mechanisms, most notably, inflammation and oxidative stress. In I/R injury, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) produces reactive oxygen species (ROS), which promote inflammatory and apoptotic pathways, augmenting ROS production and promoting cell death. Inhibiting ischemia-induced oxidative stress would be beneficial for reducing neuroinflammation and promoting neuronal cell survival. Studies have demonstrated that chlorpromazine and promethazine (C+P) induce neuroprotection. This study investigated how C+P minimizes oxidative stress triggered by ischemic injury. Adult male Sprague-Dawley rats were subject to middle cerebral artery occlusion (MCAO) and subsequent reperfusion. 8 mg/kg of C+P was injected into the rats when reperfusion was initiated. Neurologic damage was evaluated using infarct volumes, neurological deficit scoring, and TUNEL assays. NOX enzymatic activity, ROS production, protein expression of NOX subunits, manganese superoxide dismutase (MnSOD), and phosphorylation of PKC- were assessed. Neural SHSY5Y cells underwent oxygen-glucose deprivation (OGD) and subsequent reoxygenation and C+P treatment. We also evaluated ROS levels and NOX protein subunit expression, MnSOD, and p-PKC-/PKC-. Additionally, we measured PKC- membrane translocation and the level of interaction between NOX subunit (p47) and PKC- via coimmunoprecipitation. As hypothesized, treatment with C+P therapy decreased levels of neurologic damage. ROS production, NOX subunit expression, NOX activity, and p-PKC-/PKC- were all significantly decreased in subjects treated with C+P. C+P decreased membrane translocation of PKC- and lowered the level of interaction between p47 and PKC-. This study suggests that C+P induces neuroprotective effects in ischemic stroke through inhibiting oxidative stress. Our findings also indicate that PKC-, NOX, and MnSOD are vital regulators of oxidative processes, suggesting that C+P may serve as an antioxidant.

Citing Articles

CB1 Receptor Activation Provides Neuroprotection in an Animal Model of Glutamate-Induced Excitotoxicity Through a Reduction of NOX-2 Activity and Oxidative Stress.

Martinez-Torres A, Moran J CNS Neurosci Ther. 2024; 30(11):e70099.

PMID: 39496572 PMC: 11534500. DOI: 10.1111/cns.70099.


Identification of key potassium channel genes of temporal lobe epilepsy by bioinformatics analyses and experimental verification.

Zhang L, Chen L, Zhao Y, Duan W, Zhong L, Liu M Front Neurol. 2023; 14:1175007.

PMID: 37483435 PMC: 10361730. DOI: 10.3389/fneur.2023.1175007.

References
1.
Maier C, Hsieh L, Crandall T, Narasimhan P, Chan P . Evaluating therapeutic targets for reperfusion-related brain hemorrhage. Ann Neurol. 2006; 59(6):929-38. DOI: 10.1002/ana.20850. View

2.
Geng X, Fu P, Ji X, Peng C, Fredrickson V, Sy C . Synergetic neuroprotection of normobaric oxygenation and ethanol in ischemic stroke through improved oxidative mechanism. Stroke. 2013; 44(5):1418-25. DOI: 10.1161/STROKEAHA.111.000315. View

3.
Xie W, Zhu T, Zhou P, Xu H, Meng X, Ding T . Notoginseng Leaf Triterpenes Ameliorates OGD/R-Induced Neuronal Injury via SIRT1/2/3-Foxo3a-MnSOD/PGC-1 Signaling Pathways Mediated by the NAMPT-NAD Pathway. Oxid Med Cell Longev. 2020; 2020:7308386. PMC: 7603631. DOI: 10.1155/2020/7308386. View

4.
Guo S, Cosky E, Li F, Guan L, Ji Y, Wei W . An inhibitory and beneficial effect of chlorpromazine and promethazine (C + P) on hyperglycolysis through HIF-1α regulation in ischemic stroke. Brain Res. 2021; 1763:147463. DOI: 10.1016/j.brainres.2021.147463. View

5.
Yang C, Yang S, Lee T, Fang J, Lin C, Jou M . Evaluation of Anti-Inflammatory Effects of Helminthostachys zeylanica Extracts via Inhibiting Bradykinin-Induced MMP-9 Expression in Brain Astrocytes. Mol Neurobiol. 2015; 53(9):5995-6005. DOI: 10.1007/s12035-015-9511-9. View